Skip to content

Predictors of Exposure Success in Public Speaking Anxiety

Predictors of Exposure Success in Public Speaking Anxiety

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02163148
Enrollment
24
Registered
2014-06-13
Start date
2014-05-31
Completion date
2014-12-31
Last updated
2015-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Performance Anxiety

Brief summary

Anxiety disorders are common and impairing. Although exposure therapy is one of the most effective treatments for anxiety, some individuals do not fully respond to treatment, and these individual differences are not well understood. Exposure therapy involves repeated, deliberate, safe engagement with a feared stimulus without the feared outcome occurring. This treatment is thought to work through a type of emotional learning called fear extinction. This study aims to look at links between fear extinction learning and exposure success, with the overall goal of better understanding who is likely to respond best to exposure therapy and why.

Interventions

BEHAVIORALMassed speech exposure session

One session consisting of 4 speech exposures, each 5 minutes long.

Sponsors

University of California, San Diego
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Score of at least 20 on the PRCS * Age 18-55 * English fluency

Exclusion criteria

* Psychotropic medication use in the past 4 weeks * Past experience with exposure based therapy * History of bipolar disorder, psychotic disorder, or substance dependence * Current major depressive disorder of greater than moderate severity (defined as a score on the 9 item Patient Health Questionnaire of greater than 14) * Clinically significant suicidal or homicidal ideation * Non-removable ferrous metal * Current significant neurological conditions * History of loss of consciousness greater than 5 minutes duration * Pregnant * Claustrophobic

Design outcomes

Primary

MeasureTime frameDescription
Change in peak Subjective Unit of Distress (SUDS) rating from first to fourth (last) exposure90 minutesParticipants will complete 4 exposures during one 90 minute session. Change in the peak ratings on the final exposure relative to the first exposure will be the outcome measure.

Secondary

MeasureTime frame
Change from baseline on the Liebowitz Social Anxiety Scale (LSAS) at 2 weeksBaseline, week 2
Change from baseline on the Personal Report of Confidence as a Speaker (PRCS) at 2 weeksBaseline, week 2

Other

MeasureTime frame
Change from baseline on the Sheehan Disability Scale (SDS) at week 2Baseline, week 2

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026